Review Article

Vaccines for TB: Lessons from the Past Translating into Future Potentials

Table 1

Candidate vaccine with emerging protective responses and its brief description.

TB vaccineVaccine details

MVA85A [45]Modified Vaccinia Ankara virus expressing Ag85A

VPM1002 [50]rBCG expressing listeriolysin

AdAg85A [89]Adenovirus expressing Ag85A

ΔIKEPLUS [90]Mycobacterium smegmatis mutant that expresses M. tb esx-3 genes which is capable of inducing central memory responses

SO2 [52]Mutant M. tb strain that has phoP deleted

Hybrid 1 + IC31 [91]Fusion of ESAT-6 and Ag85B in adjuvant IC31

H4 [57]Ag85B and TB10.4 administered with IC31 or DDA/MPL

H56 [58]Ag85B and ESAT-6 administered with IC31

rBCG30 [92, 93]30-kDa major secretory protein of Mycobacterium tuberculosis

M72 + AS01/AS02 [94]Fusion protein of Rv1196 and Rv0125 in AS01 or AS02 adjuvant